Jessica Garbern, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocytes, Cardiac | 9 | 2024 | 1667 | 1.950 |
Why?
|
Regenerative Medicine | 3 | 2022 | 306 | 1.270 |
Why?
|
Regeneration | 4 | 2022 | 1505 | 1.240 |
Why?
|
Pluripotent Stem Cells | 3 | 2021 | 796 | 0.940 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2024 | 1850 | 0.900 |
Why?
|
Myocardium | 5 | 2022 | 4724 | 0.850 |
Why?
|
Growth Differentiation Factors | 2 | 2019 | 100 | 0.770 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2019 | 829 | 0.760 |
Why?
|
Naphthyridines | 1 | 2019 | 143 | 0.630 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2019 | 841 | 0.570 |
Why?
|
Stem Cell Transplantation | 3 | 2022 | 1600 | 0.560 |
Why?
|
Integrases | 1 | 2019 | 518 | 0.550 |
Why?
|
Cardiomyopathies | 2 | 2020 | 1948 | 0.540 |
Why?
|
Heart | 2 | 2022 | 4403 | 0.480 |
Why?
|
Gene Deletion | 2 | 2019 | 2661 | 0.480 |
Why?
|
Myoblasts, Cardiac | 1 | 2013 | 21 | 0.440 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2024 | 2917 | 0.430 |
Why?
|
Endothelial Cells | 2 | 2023 | 3548 | 0.410 |
Why?
|
Acrylamides | 2 | 2010 | 259 | 0.390 |
Why?
|
Fibrosis | 1 | 2019 | 2045 | 0.390 |
Why?
|
Heart Failure | 5 | 2020 | 11669 | 0.380 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2057 | 0.360 |
Why?
|
Angiogenic Proteins | 1 | 2010 | 101 | 0.340 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2010 | 592 | 0.310 |
Why?
|
Myocarditis | 1 | 2015 | 788 | 0.300 |
Why?
|
Heart Transplantation | 2 | 2020 | 3232 | 0.260 |
Why?
|
Neovascularization, Physiologic | 2 | 2010 | 1349 | 0.250 |
Why?
|
Cell Differentiation | 5 | 2024 | 11514 | 0.240 |
Why?
|
Hydrogels | 1 | 2010 | 720 | 0.240 |
Why?
|
Heart Diseases | 2 | 2013 | 2778 | 0.220 |
Why?
|
DNA Adducts | 1 | 2023 | 94 | 0.220 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18221 | 0.180 |
Why?
|
Toluene | 1 | 2019 | 32 | 0.170 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2222 | 0.160 |
Why?
|
Benzothiazoles | 1 | 2019 | 247 | 0.160 |
Why?
|
Myosin Heavy Chains | 1 | 2019 | 404 | 0.140 |
Why?
|
Injections | 2 | 2010 | 832 | 0.140 |
Why?
|
Sirtuins | 1 | 2020 | 319 | 0.140 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2020 | 597 | 0.140 |
Why?
|
Nanomedicine | 1 | 2019 | 289 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15498 | 0.130 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2495 | 0.130 |
Why?
|
Embryo, Mammalian | 1 | 2021 | 1670 | 0.120 |
Why?
|
Diffusion of Innovation | 1 | 2020 | 729 | 0.120 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1608 | 0.120 |
Why?
|
Animals | 11 | 2023 | 168201 | 0.110 |
Why?
|
Imidazoles | 1 | 2019 | 1175 | 0.110 |
Why?
|
Snakes | 1 | 2013 | 27 | 0.110 |
Why?
|
Amphibians | 1 | 2013 | 29 | 0.110 |
Why?
|
Cell Line | 2 | 2019 | 15576 | 0.100 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 1265 | 0.100 |
Why?
|
Waiting Lists | 1 | 2015 | 764 | 0.090 |
Why?
|
Age Factors | 2 | 2019 | 18381 | 0.090 |
Why?
|
Forecasting | 1 | 2020 | 2924 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2019 | 2049 | 0.090 |
Why?
|
Cells, Cultured | 4 | 2024 | 18937 | 0.090 |
Why?
|
DNA | 1 | 2023 | 7196 | 0.080 |
Why?
|
Biotin | 1 | 2010 | 252 | 0.080 |
Why?
|
Myocardial Infarction | 1 | 2010 | 11459 | 0.080 |
Why?
|
Humans | 16 | 2024 | 760617 | 0.080 |
Why?
|
Rats, Inbred F344 | 1 | 2010 | 826 | 0.080 |
Why?
|
Viscosity | 1 | 2010 | 336 | 0.080 |
Why?
|
Recovery of Function | 1 | 2020 | 2978 | 0.080 |
Why?
|
Piperazines | 1 | 2019 | 2521 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2118 | 0.080 |
Why?
|
Systole | 1 | 2010 | 935 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3794 | 0.080 |
Why?
|
Mitochondria | 1 | 2021 | 3619 | 0.070 |
Why?
|
Mammals | 1 | 2013 | 1131 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2909 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2019 | 3796 | 0.070 |
Why?
|
Graft Rejection | 1 | 2020 | 4446 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3873 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6474 | 0.060 |
Why?
|
Cyclic N-Oxides | 1 | 2005 | 72 | 0.060 |
Why?
|
Graft Survival | 1 | 2015 | 3820 | 0.060 |
Why?
|
Coronary Circulation | 1 | 2010 | 1569 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11874 | 0.060 |
Why?
|
Rats | 4 | 2023 | 23717 | 0.060 |
Why?
|
Mice, Knockout | 1 | 2019 | 14389 | 0.060 |
Why?
|
Temperature | 1 | 2010 | 2223 | 0.050 |
Why?
|
Aging | 1 | 2022 | 8699 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12043 | 0.050 |
Why?
|
Electricity | 1 | 2023 | 175 | 0.050 |
Why?
|
Rodentia | 1 | 2023 | 261 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13495 | 0.050 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2004 | 278 | 0.050 |
Why?
|
Zebrafish | 1 | 2013 | 3007 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16571 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12447 | 0.050 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22115 | 0.050 |
Why?
|
Databases, Factual | 1 | 2015 | 7960 | 0.040 |
Why?
|
Child | 3 | 2020 | 80079 | 0.040 |
Why?
|
Signal Transduction | 2 | 2024 | 23416 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6403 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 982 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6233 | 0.040 |
Why?
|
Male | 8 | 2023 | 360358 | 0.040 |
Why?
|
Infant | 2 | 2020 | 36152 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1055 | 0.040 |
Why?
|
Ultrasonography | 1 | 2010 | 5964 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15612 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17878 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1186 | 0.040 |
Why?
|
Child, Preschool | 2 | 2020 | 42188 | 0.030 |
Why?
|
Antioxidants | 1 | 2005 | 1668 | 0.030 |
Why?
|
Hepatocytes | 1 | 2004 | 1231 | 0.030 |
Why?
|
NAD | 1 | 2020 | 614 | 0.030 |
Why?
|
Mice | 3 | 2019 | 81368 | 0.030 |
Why?
|
Lysine | 1 | 2020 | 993 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2020 | 3591 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23972 | 0.030 |
Why?
|
Female | 5 | 2023 | 392148 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 39913 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2005 | 3113 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3492 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 74115 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 88234 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 4804 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2020 | 80566 | 0.020 |
Why?
|
Inflammation | 1 | 2010 | 10760 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8311 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2015 | 64568 | 0.020 |
Why?
|
Chromatin | 1 | 2020 | 2955 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2020 | 3095 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2020 | 4470 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6762 | 0.020 |
Why?
|
United States | 1 | 2015 | 72272 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3394 | 0.020 |
Why?
|
Rats, Inbred WKY | 1 | 2005 | 150 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 2005 | 186 | 0.020 |
Why?
|
Hypertension | 1 | 2005 | 8529 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9461 | 0.010 |
Why?
|
Drinking | 1 | 2005 | 198 | 0.010 |
Why?
|
Superoxides | 1 | 2005 | 387 | 0.010 |
Why?
|
Spin Labels | 1 | 2005 | 337 | 0.010 |
Why?
|
Microspheres | 1 | 2004 | 782 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26180 | 0.010 |
Why?
|
Mice, SCID | 1 | 2004 | 2625 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39063 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2639 | 0.010 |
Why?
|
Aorta | 1 | 2005 | 2041 | 0.010 |
Why?
|
Body Weight | 1 | 2005 | 4614 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 5780 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59179 | 0.010 |
Why?
|
Blood Pressure | 1 | 2005 | 8472 | 0.010 |
Why?
|